QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.066761v1 310/3/1161    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mantey, S. A. Articles by Jensen, R. T. Search for Related Content PubMed PubMed Citation Articles by Mantey, S. A. Articles by Jensen, R. T.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3

Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (S.A.M., L.K.E., R.T.J.); and Peptide Research Laboratories, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana (D.H.C.)

The human bombesin receptor subtype 3 (hBRS-3) orphan receptor, which has a high homology to bombesin (Bn) receptors [gastrin-releasing peptide (GRP) and neuromedin B (NMB) receptors], is widely distributed in the rat central nervous system. Its natural ligand or role in physiology is unknown due to lack of selective ligands. Its target disruption leads to obesity, diabetes, and hypertension. A synthetic high-affinity agonist, [D-Tyr⁶,-Ala¹¹,Phe¹³,Nle¹⁴]Bn(6-14), has been described, but it is nonselective for hBRS-3 over other Bn receptors; however, substitution of (R)- or (S)-amino-3-phenylpropionic acid (Apa) for -Ala¹¹ resulted in a modestly selective ligand. In the present study, we have attempted to develop a more selective hBRS-3 ligand by using two strategies: substitutions on phenyl ring of Apa¹¹ and the substitution of other conformationally restricted amino acids into position 11 of [D-Tyr⁶,-Ala¹¹,Phe¹³,Nle¹⁴]Bn(6-14). Fifteen analogs were synthesized and affinities were determined for hBRS-3 and Bn receptors (hGRP-R and hNMB-R). Selective analogs were tested for their ability to activate each receptor by stimulating phospholipase C. One analog, [D-Tyr⁶,Apa-4Cl,Phe¹³,Nle¹⁴]Bn(6-14), retained high affinity for the hBRS-3 (K_i = 8 nM) and had enhanced selectivity (>230-fold) for hBRS-3 over hGRP-R or hNMB-R. This analog specifically interacted with hBRS-3, fully activated hBRS-3 receptors, and was a potent agonist at the hBRS-3 receptor. This enhanced selectivity should allow this analog to be useful for investigating the possible role of hBRS-3 in physiological or pathological processes.

Address correspondence to: Dr. Robert T. Jensen, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg. 10, Room 9C-103, 10 Center Dr., MSC 1804, Bethesda, MD 20892-1804. E-mail: robertj{at}bdg10.niddk.nih.gov

This article has been cited by other articles:

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				N. Gonzalez, S. J. Hocart, S. Portal-Nunez, S. A. Mantey, T. Nakagawa, E. Zudaire, D. H. Coy, and R. T. Jensen Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 463 - 474. [Abstract] [Full Text] [PDF]

				M. Subramaniam, C. Bausch, A. Twomey, S. Andreeva, B. A. Yoder, L. Chang, J. D. Crapo, R. A. Pierce, F. Cuttitta, and M. E. Sunday Bombesin-like Peptides Modulate Alveolarization and Angiogenesis in Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 902 - 912. [Abstract] [Full Text] [PDF]

				S. A. Mantey, N. Gonzalez, M. Schumann, T. K. Pradhan, L. Shen, D. H. Coy, and R. T. Jensen Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 980 - 989. [Abstract] [Full Text] [PDF]

				K. Ashour, L. Shan, J. H. Lee, W. Schlicher, K. Wada, E. Wada, and M. E. Sunday Bombesin Inhibits Alveolarization and Promotes Pulmonary Fibrosis in Newborn Mice Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1377 - 1385. [Abstract] [Full Text] [PDF]